These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16956956)

  • 1. Characterization of human urinary metabolites of the antimalarial piperaquine.
    Tarning J; Bergqvist Y; Day NP; Bergquist J; Arvidsson B; White NJ; Ashton M; Lindegårdh N
    Drug Metab Dispos; 2006 Dec; 34(12):2011-9. PubMed ID: 16956956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolite identification of the antimalarial piperaquine in vivo using liquid chromatography-high-resolution mass spectrometry in combination with multiple data-mining tools in tandem.
    Yang A; Zang M; Liu H; Fan P; Xing J
    Biomed Chromatogr; 2016 Aug; 30(8):1324-30. PubMed ID: 26821381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of Piperaquine to Its Antiplasmodial Metabolites and Their Pharmacokinetic Profiles in Healthy Volunteers.
    Liu H; Zhou H; Cai T; Yang A; Zang M; Xing J
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS/MS quantitation of antimalarial drug piperaquine and metabolites in human plasma.
    Aziz MY; Hoffmann KJ; Ashton M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():253-258. PubMed ID: 28863865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auto-induction of phase I and phase II metabolism of artemisinin in healthy Chinese subjects after oral administration of a new artemisinin-piperaquine fixed combination.
    Zang M; Zhu F; Li X; Yang A; Xing J
    Malar J; 2014 Jun; 13():214. PubMed ID: 24889062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectroscopic methodologies and molecular docking studies on the interaction of antimalarial drug piperaquine and its metabolites with human serum albumin.
    Ma R; Guo DX; Li HF; Liu HX; Zhang YR; Ji JB; Xing J; Wang SQ
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Nov; 222():117158. PubMed ID: 31181505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatography-tandem mass spectrometry assay for the quantitation of beta-dihydroartemisinin in rat plasma.
    Xing J; Yan HX; Wang RL; Zhang LF; Zhang SQ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):202-7. PubMed ID: 17267300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid identification of phase I and II metabolites of artemisinin antimalarials using LTQ-Orbitrap hybrid mass spectrometer in combination with online hydrogen/deuterium exchange technique.
    Liu T; Du F; Wan Y; Zhu F; Xing J
    J Mass Spectrom; 2011 Aug; 46(8):725-33. PubMed ID: 21766391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an isomer impurity in piperaquine drug substance.
    Lindegårdh N; Giorgi F; Galletti B; Di Mattia M; Quaglia M; Carnevale D; White NJ; Mazzanti A; Day NP
    J Chromatogr A; 2006 Dec; 1135(2):166-9. PubMed ID: 17046006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of the antimalarial piperaquine in plasma.
    Tarning J; Lindegardh N
    Trans R Soc Trop Med Hyg; 2008 May; 102(5):409-11. PubMed ID: 18378269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the antimalarial drug piperaquine in small volume pediatric plasma samples by LC-MS/MS.
    Kjellin LL; Dorsey G; Rosenthal PJ; Aweeka F; Huang L
    Bioanalysis; 2014; 6(23):3081-9. PubMed ID: 25529877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects.
    Röshammar D; Hai TN; Friberg Hietala S; Van Huong N; Ashton M
    Eur J Clin Pharmacol; 2006 May; 62(5):335-41. PubMed ID: 16570188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.
    Benjamin JM; Moore BR; Salman S; Page-Sharp M; Tawat S; Yadi G; Lorry L; Siba PM; Batty KT; Robinson LJ; Mueller I; Davis TM
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4260-71. PubMed ID: 25963981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Avula B; Tekwani BL; Chaurasiya ND; Fasinu P; Dhammika Nanayakkara NP; Bhandara Herath HMT; Wang YH; Bae JY; Khan SI; Elsohly MA; McChesney JD; Zimmerman PA; Khan IA; Walker LA
    Malar J; 2018 Aug; 17(1):294. PubMed ID: 30103751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of piperaquine and its N-oxidated metabolite in rat plasma using LC-MS/MS.
    Liu H; Zang M; Yang A; Ji J; Xing J
    Biomed Chromatogr; 2017 Oct; 31(10):. PubMed ID: 28299804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioequivalence evaluation of two fixed-dose tablet formulations of dihydroartemisinin and piperaquine in Vietnamese subjects.
    Chinh NT; Quang NN; Thanh NX; Dai B; Geue JP; Addison RS; Travers T; Edstein MD
    Antimicrob Agents Chemother; 2009 Feb; 53(2):828-31. PubMed ID: 19047656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoinduction of phase I and phase II metabolism of artemisinin in rats.
    Xing J; Du FY; Liu T; Zhu FP
    Xenobiotica; 2012 Sep; 42(9):929-38. PubMed ID: 22455462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive and rapid liquid chromatography/tandem mass spectrometric assay for the quantification of piperaquine in human plasma.
    Singhal P; Gaur A; Gautam A; Varshney B; Paliwal J; Batra V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):24-9. PubMed ID: 17923446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda.
    Wallender E; Zhang N; Conrad M; Kakuru A; Muhindo M; Tumwebaze P; Kajubi R; Mota D; Legac J; Jagannathan P; Havlir D; Kamya M; Dorsey G; Aweeka F; Rosenthal PJ; Savic RM
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30530597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential kinetic profiles and metabolism of primaquine enantiomers by human hepatocytes.
    Fasinu PS; Avula B; Tekwani BL; Nanayakkara NP; Wang YH; Bandara Herath HM; McChesney JD; Reichard GA; Marcsisin SR; Elsohly MA; Khan SI; Khan IA; Walker LA
    Malar J; 2016 Apr; 15():224. PubMed ID: 27093859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.